What medication can be given for sea motion sickness and what is the appropriate ICD‑10‑CM code to use?

Medication for Sea Motion Sickness

For sea motion sickness, use scopolamine (transdermal patch) as first-line therapy, applied 4-6 hours before travel, or alternatively use first-generation antihistamines like meclizine (25-50 mg) or dimenhydrinate (50 mg) 1-2 hours before departure; the appropriate ICD-10-CM code is T75.3XXA (Motion sickness, initial encounter).

Medication Selection Algorithm

First-Line: Scopolamine (Hyoscine)

• Transdermal patch is the most effective preventive agent 1
• Apply 4-6 hours before anticipated motion exposure 2
• Superior efficacy compared to placebo in preventing symptoms 1
• Delivers medication over 72 hours
• Caveat: May cause dry mouth, blurred vision, and drowsiness 1, 3

Second-Line: First-Generation Antihistamines

When scopolamine is contraindicated or unavailable 2:

• Meclizine: 25-50 mg orally 1-2 hours before travel 2

  • Equivalent efficacy to scopolamine in comparative studies 3
  • Well-tolerated with minimal CNS effects 4

• Dimenhydrinate: 50 mg orally 1-2 hours before travel 2

  • Comparable effectiveness to other antihistamines 3
  • More sedating than meclizine

• Cinnarizine: Effective but not available in the United States 3

Medications to AVOID

• Ondansetron: NOT effective for motion sickness prevention 2
• Non-sedating antihistamines: Ineffective 2
• Ginger root: Not effective 2

Evidence Quality Discussion

The recommendation for scopolamine is based on a Cochrane systematic review 1 demonstrating clear superiority over placebo. A 1994 comparative study of seven agents showed no significant difference between scopolamine, meclizine, dimenhydrinate, and cinnarizine (4.1-10.2% vomiting rates across all groups) 3, though scopolamine had slightly more visual side effects.

Recent evidence from 2025 shows tradipitant (NK1 receptor antagonist) significantly reduced vomiting compared to placebo (18-19% vs 44%, p<0.0001) 5, but this is not yet FDA-approved or widely available for motion sickness.

Clinical Considerations

Timing is critical: Medications must be given before symptom onset 2. Once nausea begins, oral medications are poorly absorbed and less effective.

Behavioral strategies should complement pharmacotherapy 2:

• Position in the most stable part of the vessel (center, lower deck)
• Focus on the horizon
• Avoid reading or screen time
• Lie down with eyes closed if possible

Important contraindications:

• Scopolamine: Narrow-angle glaucoma, urinary retention, severe liver/kidney disease
• Antihistamines: Caution in elderly due to anticholinergic effects

ICD-10-CM Coding

T75.3XXA - Motion sickness, initial encounter

• Use T75.3XXD for subsequent encounters
• Use T75.3XXS for sequelae

Alternative codes if complications present:

• R11.0 - Nausea (if primary symptom)
• R11.2 - Nausea with vomiting

Common Pitfalls

1. Waiting until symptoms start: Prophylaxis must begin hours before exposure 2
2. Using ondansetron: Despite its use for other causes of nausea, it is ineffective for motion sickness 2
3. Inadequate patch application time: Scopolamine patches need 4-6 hours to reach therapeutic levels 2
4. Combining multiple sedating agents: Increases risk of excessive drowsiness without added benefit